craniofacial anomalies
Post on 30-Dec-2015
25 views
Embed Size (px)
DESCRIPTION
Craniofacial anomalies. HuGENet NETWORK OF NETWORKS WORKSHOP October 2005. Julian Little Canada Research Chair in Human Genome Epidemiology Department of Epidemiology & Community Medicine University of Ottawa. Origins. WHO Human Genetics Programme, 2000 Financial support from NIDCR (US) - PowerPoint PPT PresentationTRANSCRIPT
Craniofacial anomaliesJulian LittleCanada Research Chair in Human Genome EpidemiologyDepartment of Epidemiology & Community MedicineUniversity of Ottawa
HuGENet NETWORK OF NETWORKS WORKSHOP
October 2005
OriginsWHO Human Genetics Programme, 2000Financial support from NIDCR (US)Five-year project designed to take forward international strategy on craniofacial anomalies
Objectives of WHO project
to develop an international network for consensus building, planning and development for international collaborative biomedical, epidemiological and behavioural studies in the core areas of craniofacial anomalies researchto create a directory of research resources in craniofacial anomalies. to create the International Database on Craniofacial Anomalies (CFA)
Core areas
genetic basis of CFA gene-environment interactions involved in CFA prevention of CFA optimal treatment of CFA
Consensus meetingsNov 2000 concurrent workshops on (1) genetic basis (2) g-e interaction (3) treatmentMay 2001 preventionDec 2001 global registry
20032002
Consensus meetingsNov 2000 concurrent workshops on (1) genetic basis (2) g-e interaction (3) treatmentMay 2001 preventionDec 2001 global registryDec 2004 progress and future strategies________
Reported investigations on gene-environment interaction in aetiology of oral clefts
Variants of
Maternal exposure
Smoking
Vitamin
Alcohol
Occup
exp
Medication
Supps
A
Folate/FA
TGF
8
2
1
2
TGF3
4
2
MSX1
3
2
BCL3
1
CYP1A1
1
EPHX1
1
GSTM1
1
1
GSTT1
1
1
NAT1
1
1
1
NAT2
2
1
1
RARA
1
1
MTHFR
2
2
RFC
1
Gene-environment interaction and oral clefts: data and sample collections
Area, period
(ref)
Design
Genotyping
of
CL(P)
n
CP
n
Variants
reported
Maternal
exposures
reported
Denmark, 1991-4
(Christensen et al., 1999;
Mitchell et al., 2001, 2003)
Case-
control
Infant
233
83
TGF
TGF3
MSX1
RARA
Smoking
Alcohol
Vitamins
Liver
Netherlands, 1997-2000
(van Rooij et al., 2001, 2002,
2003)
Case-
control
Infant &
maternal
146
n.s.
CYP1A1
GSTT1
NAT2
MTHFR
Smoking
Medications
FA
Folate
Norway, 1996-8
(Jugessur et al., 2003a,b)
Case-
parent
trio
Infant,
maternal,
paternal
173
88
TGF
MTHFR
Smoking
Alcohol
Vitamins
FA
USA, California, 1987-9
(Shaw et al., 1996, 1998a,b,
1999, 2003a, b; Lammer
et al., 2004a,b; Hartsfield
et al., 2001)
Case-
control
Infant
447
215
TGF
EPHX1
GSTM1
GSTT1
NAT1/2
MHFR
RFC
Smoking (& P)
Vitamins
13 occupational
Chemical
groups
USA, Iowa, 1987-94
(Romitti et al., 1999)
Case-
control
Infant
154
60
TGF
TGF3
MSX1
Smoking
Alcohol
USA, Maryland, 1984-92
(Hwang et al., 1995; Beaty
et al., 1997, 2002; Maestri
et al., 1997)
Case-
control &
trio
Infant,
maternal,
paternal
186
83
TGF
TGF3
MSX1
BCL1
Smoking
Identifying teams
List developed from WHO reports and literature searchesAsked those who attended WHO meetings (1) about concept (2) to review list and extend if possibleContact additional teams identified
Teamswith established data and sample collections with ongoing data and sample collectionsplanning to establish data and sample collections
Numbers of teams
WHO regionEstablishedOngoingPlannedMulticountry in >1 region2 (trios and other familial)3 (trios and other familial)-AFR--1AMR8 (cc & trio)1 multicountry; 1 multistate; 12EMR--1EUR1 multicountry (trio);9 (cc & trio)1 cohortSEAR4 (cc & trio)-3
N of cases from cc studies; trios; samples; (studies)
WHO regionEstablishedOngoingPlanned>1? + > 2000 trios3 (trios and other familial)-AFR--(1)AMR1343 cc (5); 324 trios (3); >7000 samples (1) 1 multicountry; 1 multistate 2100cc but bio samp from 600 only;(2)EMR--(1)EURmulticountry 1169 trios; 1227 cc (9); 651 trios (4)1 cohortSEAR259 cc (3) & 213 trios (2)-(3)
Co-ordinationOttawaDundee (Peter Mossey)Iowa (Jeff Murray)
Funding
Other issuesDifferent designsSamplesGovernanceFurther analyses possible?Outside country?Elsewhere within country?Only in own centre?
May be overlap between cc and trio counts. Sometimes more controls than cases